(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LASSIE GENTLE DIABETES CARE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

LASSIE GENTLE DIABETES CARE

ST13

US500000079314138

Class

9, 10, 42

Filing

79314138

Registration

6854543

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

02/14/2023

Trademark type

Combined

Nice classes

9, 10, 42

Filing date

03/22/2021

Registration date

09/27/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/27/2022

Last transaction

09/27/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

34

Owner location

FR

Examiner

CANTONE, KERI H

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

BOYDSENSE

Representatives

Nicholas D. Wells Legends Law Group

Technical classification

Nice Classes

Class 9Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Measuring apparatus and instruments for measuring gas concentration; gas sensors and apparatus for measuring volatile organic compounds; dowloadable software for use in data management for medical use; downloadable software for medical use for assisting users with the provided measuring apparatus and instruments; downloadable software for medical monitoringmanagement and organization of patient data; downloadable software for medical monitoringmanaging and organization of patient data; embedded software for a portable breath-detection apparatus used for detecting diabetes and blood sugar levels in individuals; downloadable software and applications for mobile telephonestablet computers and other mobile electronic devicesin the field of preventionmanagement and treatment of diabetes for management and organization of patient data

Class 10

Sensor for use in medical diagnosis to gather human biometric data; detection apparatus in the nature of sensors and alarms for medical use for patient monitoring; control measurement apparatus for medical usecontrol unit using breath as a fluid to estimate blood sugar values; mobile physiological monitoring apparatus and analysis apparatus for medical usemedical diagnostic instruments for the analysis of body fluid; blood glucose monitoring system; glucose-level monitoring devices for medical purposes; apparatus for analysis of substances in gases for medical use in the nature of a gas sensor for medical use; apparatus for analysis of substances for medical useorganic compounds and biomarkersbody composition analyzers for medical purposes; analytical devices for medical usefor breath analysis; analytical devices for medical usefor breath analysis to estimate blood sugar values; mobile monitoring apparatus and apparatus for analysis for medical usefor breath analysis to estimate blood sugar values

Class 42

Design and development of softwaredownloadable software and downloadable applications for mobile telephonestablet computers and other mobile electronic devices in the field of preventionmanagement and treatment of diabetes; electronic storage and back-up of information and data in the field of preventionmanagement and treatment of diabetes; design of mobile applications for individuals to recordtrack and generate reports regarding the statustreatment and management of diabetes; provision of scientific research information relating to diabetes via downloadable applications for mobile telephonestablet computers and other mobile electronic devices

Publications

History of USPTO decisions and trademark events.

30 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/14/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/23/2023

FIMP

FINAL DISPOSITION PROCESSED

01/23/2023

GPNX

NOTIFICATION PROCESSED BY IB

12/28/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/27/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/03/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/03/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/03/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/03/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/03/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/27/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

09/27/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/12/2022

PUBO

PUBLISHED FOR OPPOSITION

07/12/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

06/29/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

06/29/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/22/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/06/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/12/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/11/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/11/2022

RFNT

REFUSAL PROCESSED BY IB

12/26/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/06/2021

RFRR

REFUSAL PROCESSED BY MPU

12/06/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/04/2021

CNRT

NON-FINAL ACTION WRITTEN

11/03/2021

DOCK

ASSIGNED TO EXAMINER

10/26/2021

MAFR

APPLICATION FILING RECEIPT MAILED

07/02/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/28/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/25/2021

Continuous trademark protection

Get notified about every new filing that threatens LASSIE GENTLE DIABETES CARE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.